MedPath

Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail?

Phase 1
Conditions
People with challenging behavior and off-label antipsychotic use
Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
Registration Number
EUCTR2016-002859-19-NL
Lead Sponsor
Erasmus MC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Adults, >18 years
Intellectual disability, IQ<70
Living at one of the participating care-organisations
Off-label use of risperidone or pipamperone because of challenging behavior > half year
ZZP>3

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 125
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 1

Exclusion Criteria

On-label antipsychotic use
Active delirium <1 month
Failed antipsychotic withdrawal last 6 months
Use >1 antipsychotic

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath